Condition: Chronic Kidney Disease Stage 3 and 4 · Peripheral Artery Disease (PAD) · Sponsor: University Hospital of Ferrara
People affected by chronic kidney disease and concomitant diagnosed peripheral artery disease at intermediate stages, without contraindications to exercise therapy will be invited to participate in the study. Whose providing informed consent, will be randomly assigned to one of two groups: 1. Exercise program receiving two daily 10-minute interval walking sessions at a slow increasing speed. 2. Control group: receiving usual care including optimal medical therapy and nutritional advice. Patients of both groups will be measured at baseline, after the end of the exercise program (6-month) and at follow up (12-month). Outcome measures will include walking ability by the 6-minute walking test (primary outcome) and lower limbs perfusion, body composition, quality of life, laboratory outcomes and long-term hospitalizations.
This description comes directly from the study's public registry record.
Fabio Manfredini Prof. Fabio Manfredini, MD, PhD · +390532236187 · fabio.manfredini@unife.it
Always discuss trial participation with your own doctor first.
| University Hospital of Ferrara | Ferrara, Italy, Italy | Recruiting |
| Ospedale Pederzoli Peschiera del Garda | Peschiera del Garda, Italy, Italy | Recruiting |
| Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli | Reggio Calabria, Italy, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06621264